Gregory T Everson

16PUBLICATIONS
16CO-AUTHORS
Language documentation and descriptionCancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatologyRespiratory diseasesCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 11, 2026
Letter: FDA Approval of the HepQuant SHUNT Liver Diagnostic Test and Clarification of the SHUNT-V Analysis Cohort.

|Feb 12, 2026
When should I repeat the endoscopy in my patient with compensated cirrhosis, whom I just scoped and who had no or small varices?

Joanne C Imperial, Michael P McRae, Gregory T Everson

|Jan 28, 2026
Utilization of the Disease Severity Index (DSI) from the HepQuant DuO Test Enhances Clinical Decision Making in Compensated Advanced Chronic Liver Disease.

Kerry Whitaker, Joanne C Imperial, Michael P McRae

|Jan 26, 2026
HMG-CoA Reductase Inhibitors (Statins) May Preserve Hepatic Function and Reduce Portal-Systemic Shunting in Compensated Advanced Chronic Liver Disease: Results From the SHUNT-V Study.

Robert S Rahimi, Edward Mena, Kathryn J Lucas

|Mar 29, 2025
Letter: Enhancing the Diagnostic Performance of the Oral Cholate Challenge Test: Implications for Avoidance of Potentially Unnecessary Endoscopy.

Tarek Hassanein, Andrew P Keaveny, Parvez Mantry

|Mar 21, 2025
Alterations in Liver Perfusion in Adults With Fontan Circulation as Assessed by Dual Cholate Clearance.

Yuli Y Kim, Annique Nyman, Yuan-Shung Huang

Pageof 3

Frequent Collaborators

13 joint publications

Michael P McRae

3 joint publications

Andrew P Keaveny

2 joint publications

Sumeet K Asrani

2 joint publications

Steve M Helmke